Lophophine

Lophophine

Clinical data
Routes of administration	Oral
ATC code	none
Legal status
Legal status	Uncontrolled (but may be covered under the Federal Analogue Act in the United States and under similar bills in other countries due to its similarity to mescaline and MMDA)
Identifiers
IUPAC name 2-(7-Methoxy-1,3-benzodioxol-5-yl)ethanamine
CAS Number	23693-38-1 Y
PubChem CID	90239
ChemSpider	81465 Y
UNII	C68IB79RC2
ChEMBL	ChEMBL159620 Y
CompTox Dashboard (EPA)	DTXSID80178357
ECHA InfoCard	100.041.645
Chemical and physical data
Formula	C10H13NO3
Molar mass	195.218 g·mol−1
3D model (JSmol)	Interactive image
SMILES O1c2cc(cc(OC)c2OC1)CCN
InChI InChI=1S/C10H13NO3/c1-12-8-4-7(2-3-11)5-9-10(8)14-6-13-9/h4-5H,2-3,6,11H2,1H3 Y Key:ORXQUAPZHKCCAX-UHFFFAOYSA-N Y
(verify)

Lophophine (MMDPEA or 3-methoxy-4,5-methylenedioxyphenethylamine) is a putative psychedelic and entactogen drug of the methylenedioxyphenethylamine class. It is the α-demethylated homologue of MMDA, and is also closely related to mescaline.

Alexander Shulgin originally suggested that lophophine may be a natural constituent of peyote (Lophophora williamsii) due to it being the only logical chemical intermediate for the biosynthesis of several tetrahydroisoquinolines known to be present in this cactus species. Subsequently, lophophine was indeed shown to be a minor component of both peyote and San Pedro cactus.

Shulgin reports that lophophine is active in the dosage range of 150–250 mg. He states that at these doses, lophophine has some similarity to mescaline in action, in producing a peaceful elevation of mood, euphoria, and mild enhancement of visual perception, but without the generation of closed-eye mental imagery. Shulgin also notes that (in contrast to mescaline), lophophine causes no nausea.

See also

• MDPEA

External links

• PiHKAL: #95 Lophophine: 3-Methoxy-4,5-methylenedioxyphenethylamine
• Mescaline: The Chemistry and Pharmacology of its Analogues